000			02206 a2200601 4500
005			20250515160235.0
264		0	_c20090326
008			200903s 0 0 eng d
022			_a1755-5914
024	7		_a10.1111/j.1755-5922.2008.00068.x _2doi
040			_aNLM _beng _cNLM
100	1		_aLu, Ying-Mei
245	0	0	_aDY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities. _h[electronic resource]
260			_bCardiovascular therapeutics _c2009
300			_a17-27 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aAtrial Natriuretic Factor _xmetabolism
650	0	4	_aBenzylamines _xpharmacology
650	0	4	_aButadienes _xpharmacology
650	0	4	_aCalcimycin _xpharmacology
650	0	4	_aCalcium Signaling _xdrug effects
650	0	4	_aCalcium-Calmodulin-Dependent Protein Kinase Type 2 _xantagonists & inhibitors
650	0	4	_aCardiomegaly _xenzymology
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Size _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aDNA Replication _xdrug effects
650	0	4	_aEndothelin-1 _xmetabolism
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xantagonists & inhibitors
650	0	4	_aIndazoles _xpharmacology
650	0	4	_aIonophores _xpharmacology
650	0	4	_aMyocytes, Cardiac _xdrug effects
650	0	4	_aNatriuretic Peptide, Brain _xmetabolism
650	0	4	_aNitriles _xpharmacology
650	0	4	_aPhosphorylation
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aTime Factors
650	0	4	_aTransfection
700	1		_aShioda, Norifumi
700	1		_aHan, Feng
700	1		_aKamata, Akifumi
700	1		_aShirasaki, Yasufumi
700	1		_aQin, Zheng-Hong
700	1		_aFukunaga, Kohji
773	0		_tCardiovascular therapeutics _gvol. 27 _gno. 1 _gp. 17-27
856	4	0	_uhttps://doi.org/10.1111/j.1755-5922.2008.00068.x _zAvailable from publisher's website
999			_c18651224 _d18651224